A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF A UNANI FORMULATION WITH THE CURRENTLY AVAILABLE DRUGS (TAMSULOSIN & FINASTERIDE) IN THE MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS (LUTS) DUE TO BENIGN PROSTATIC HYPERPLASIA

Mohd Tarique, Tafseer Ali, Tafseer Ali

Abstract


Background: Benign prostatic hyperplasia (BPH) is a common urological problem in aging men and Phytotherapy has become a popular
treatment option, there are many different single and compound herbal products being used for the treatment of LUTS due to BPH.
Objectives: The present study compared the efficacy and safety of a Unani formulation in the management of LUTS due to BPH.
Materials and Methods: This was a single blind randomised controlled clinical trial on 73 men with moderate LUTS due to BPH who underwent
the evaluation at the baseline and at the end of the treatment. The symptoms were assessed by IPSS.
Results: After three months treatment with Unani formulation there was a statistically significant decrease of IPSS Score, without any significant
adverse effect.
Conclusion: Results demonstrate that the treatment with Unani formulation is safe and effective in the management of mild to moderate LUTS due
to BPH.


Keywords


BPH, IPSS

Full Text:

PDF

References


Ghadian A, Rezaei M, Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) Inflammo pharmacology. 2017 Aug; 25(4):451-458.

Hamvas, A., Corradi, G.Y., Hegedüs, M. and Frang, D., 1991.Experience with the Peponen® capsule in the management of benign prostatic hyperplasia. International urology and nephrology, 23(1), pp.51-55.

Hong H, Kim C-S, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutrition Research and Practice. 2009;3(4):323-327. doi:10.4162/nrp.2009.3.4.323.

Jeyaraman, R. and Patki, P.S., 2012. Clinical Evaluation of Efficacy and Safety of a Herbal Formulation in Benign Prostatic Hyperplasia: A Single Blind, Randomized, Placebo-Controlled Study. Open Journal of Urology, 2(03), p.157.

Khesal Ahmad, FA Najar, Mohd Faisal et al. Efficacy of Banadiqul-Buzoor in Improving the Quality of Life of Patients of Benign Prostatic Hypertrophy: An Open Labelled Observational Clinical Study. Research & Reviews: Journal of Surgery. 2017; 6(3): 7–11p.

KIRTIKAR, K. R., BASU B. D. Indian Medicinal Plants, volume -1, P. No.229-230.

Klippel KF, Hiltl DM, Schipp B, A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group, Br J Urol. 1997 Sep;80(3):427-32.

Machado-Leiva et al, Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study 2016 Journal of Pharmacy & Pharmacognosy Research, 4 (5), 187-198 ISSN 0719-4250.

Mohanty, N.K., Singh, U.P., Sharma, N.K., Arora, R.P. and Amitabh, V., 2006.A comparative study of fixed dose of tamsulosin with finasteride vs tamsulosin with dutasteride in the management of benign prostatic hyperplasia. Indian Journal of Urology, 22(2), p.130.

Nadkarnis, K.M. Indian Materia Medica, volume- 1, P. No. 1229-1232, third edition 1976, Bombay popular prakashan private limited.

Sahu, M., Bhat, R. and Kulkani, K., 2003. Clinical evaluation of himplasia in benign prostatic hyperplasia: an open clinical trial. Med Update, 11, pp.75-78

Said, M.M., Hassan, N.S., Schlicht, M.J. and Bosland, M.C., 2015. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia. Journal of Toxicology and Environmental Health, Part A, 78(7), pp.453-465.

Sengupta, G., Hazra, A., Kundu, A. and Ghosh, A., 2011. Comparison of Murraya koenigii–and Tribulus terrestris–based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged>50 years: a double-blind, double-dummy, randomized controlled trial. Clinical therapeutics, 33(12), pp.1943-1952.

Shrestha, B.B. and Karmacharya, M., 2015.Finasteride and Tamsulosin Combination in Benign Prostatic Enlargement in a Tertiary Hospital of Western Nepal. Journal of the Nepal Medical Association, 53(197).

Tsai, Y.S., Tong, Y.C., Cheng, J.T., Lee, C.H., Yang, F.S. and Lee, H.Y., 2006. Pumpkin seed oil and phytosterol-F can block testosterone/prazosin-induced prostate growth in rats. Urologia internationalis, 77(3), pp. 269-274.

Vahlensieck, W., Theurer, C., Pfitzer, E., Patz, B., Banik, N. and Engelmann, U., 2015. Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study. Urologia internationalis, 94(3), pp.286-295.

Zhang, W., Wang, X., Liu, Y., Tian, H., Flickinger, B., Empie, M.W. and Sun, S.Z., 2008. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. Journal of medicinal food, 11(2), pp.207-214.


Refbacks

  • There are currently no refbacks.